Summary & Overview
Thyroid, Parathyroid and Thyroglossal Procedures with CC: Inpatient Reimbursement Overview
DRG 626 covers inpatient thyroid, parathyroid, and thyroglossal procedures with a Complication or Comorbidity and reflects higher resource use than similar cases without such conditions. Accurately capturing procedures and secondary diagnoses drives correct Medicare inpatient reimbursement under Centers for Medicare & Medicaid Services payment policies.
DRG 626 Overview
DRG 626 covers inpatient admissions for thyroid, parathyroid, and thyroglossal procedures when a Complication or Comorbidity is present. It includes common surgeries such as thyroidectomy and parathyroidectomy performed for benign and malignant conditions complicated by additional diagnoses that increase resource use. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity elevates the relative weight and payment compared with cases without such complications. Proper coding of the principal procedure and secondary diagnoses determines classification and reimbursement under Centers for Medicare & Medicaid Services rules.
Clinical Trials
- Perioperative management trials evaluating strategies to reduce surgical complications in patients undergoing thyroidectomy or parathyroidectomy with significant comorbidities (eg, cardiac disease, uncontrolled diabetes) focusing on anesthesia protocols, intraoperative monitoring, and prophylactic measures to prevent hypocalcemia and nerve injury. These studies enroll adult inpatients scheduled for thyroid, parathyroid, or thyroglossal procedures who have documented complicating conditions (the CC component) and measure short-term surgical morbidity, length of stay, and ICU utilization. Results are directly relevant to surgeons, hospitalists, and payers because reducing perioperative complications can shorten inpatient LOS, lower intensive care needs, and decrease episode costs under bundled payment models.
- Comparative effectiveness research comparing surgical approaches and extent of resection (eg, total versus lobectomy for differentiated thyroid disease or focused parathyroidectomy versus bilateral exploration) in patients with complications or higher-risk features to determine outcomes such as recurrent laryngeal nerve palsy, persistent hypoparathyroidism, and reoperation rates. These trials or observational cohort studies typically include patients with CC-level complexity (multinodular goiter causing compressive symptoms, prior neck surgery, or significant comorbidity) and assess both clinical outcomes and resource use (readmissions, secondary procedures). Findings inform clinicians about tradeoffs between short-term risks and long-term disease control and help payers and hospitals optimize resource allocation and guideline-concordant care pathways.
- Post-discharge outcomes and care-coordination studies assessing risk of readmission, chronic hypocalcemia management, voice dysfunction rehabilitation, and quality-of-life after inpatient thyroid/parathyroid surgery in complicated cases. These prospective cohort or pragmatic trials investigate interventions such as structured discharge education, early endocrine follow-up, and remote monitoring of calcium levels in patients who had complications or CCs during their index admission, measuring 30–90 day readmissions, outpatient utilization, and patient-reported outcomes. This research is important to providers and payers because improving transitional care can reduce costly readmissions, improve functional recovery, and inform payment models that reward reduced downstream utilization.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.